Filana Therapeutics, Inc. SEC filings FLNA

Filana Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 9, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Filana Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Other events
Oct 20, 2026 Oct 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 22, 2026 Sep 22, 2026
8-K Current report
Listing notice
Sep 18, 2026 Sep 17, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 15, 2026 Jun 11, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 28, 2026 Jun 11, 2026
8-K Current report
Officer or director change
Apr 28, 2026 Apr 22, 2026
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Mar 10, 2026 Mar 10, 2026
8-K Current report
Regulation FD disclosure, Other events
Feb 19, 2026 Feb 19, 2026
8-K Current report
Material agreement
Dec 23, 2025 Dec 19, 2025
8-K/A Amended current report
Officer or director change
Dec 22, 2025 Oct 21, 2025
8-K Current report
Other events
Dec 18, 2025 Dec 15, 2025
8-K Current report
Officer or director change
Dec 17, 2025 Dec 12, 2025
EFFECT Filing Dec 5, 2025 —
424B2 Prospectus Dec 5, 2025 —
CORRESP Letter to the SEC Dec 3, 2025 —
8-K Current report
Other events
Dec 3, 2025 Nov 26, 2025
S-3 Shelf registration Nov 13, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Other events
Oct 24, 2025 Oct 23, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 22, 2025 Oct 21, 2025
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 8, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Regulation FD disclosure, Other events
Aug 4, 2025 Aug 4, 2025
8-K Current report
Regulation FD disclosure
Jun 30, 2025 Jun 30, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 27, 2025 May 23, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 21, 2025 Apr 15, 2025
ARS Annual report to shareholders Apr 14, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 14, 2025 May 23, 2025
PRE 14A Preliminary proxy statement Apr 3, 2025 May 23, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 25, 2025 Mar 25, 2025
8-K Current report
Officer or director change
Mar 11, 2025 Mar 6, 2025
10-K Annual report Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 3, 2025 Mar 3, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Feb 27, 2025 Feb 27, 2025
8-K Current report
Results of operations, Exit or restructuring costs, Other events
Jan 7, 2025 Jan 7, 2025
8-K Current report
Other events
Nov 25, 2024 Nov 25, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Regulation FD disclosure
Oct 8, 2024 Oct 8, 2024
8-K/A Amended current report
Officer or director change
Oct 1, 2024 Sep 6, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 27, 2024 Sep 26, 2024
8-K Current report
Other events
Sep 17, 2024 Sep 13, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 9, 2024 Sep 6, 2024
8-K/A Amended current report
Results of operations
Aug 9, 2024 Aug 8, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations, Listing notice
Aug 8, 2024 Aug 8, 2024
8-K Current report
Regulation FD disclosure
Jul 22, 2024 Jul 22, 2024
8-K Current report
Other events
Jul 18, 2024 Jul 18, 2024
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Jul 17, 2024 Jul 15, 2024
8-K Current report
Other events
Jul 1, 2024 Jul 1, 2024
8-K Current report
Officer or director change
May 22, 2024 May 20, 2024
8-K Current report
Shareholder vote results
May 13, 2024 May 9, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 10, 2024 May 10, 2024
8-K Current report
Other events
May 8, 2024 May 8, 2024
25-NSE Delisting notice May 3, 2024 —
8-K Current report
Other events
May 1, 2024 May 1, 2024
8-K Current report
Other events
Apr 15, 2024 Apr 15, 2024
DEF 14A Proxy statement Mar 26, 2024 May 9, 2024
ARS Annual report to shareholders Mar 22, 2024 Dec 31, 2023
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
8-K Current report
Other events
Feb 7, 2024 Feb 7, 2024
CERT Filing Jan 3, 2024 —
424B2 Prospectus Jan 3, 2024 —
8-A12B Filing Jan 3, 2024 —
8-K Current report
Material agreement
Jan 3, 2024 Jan 3, 2024
8-A12G Filing Jan 2, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 12, 2023 Dec 12, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 11, 2023 Dec 6, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Bylaw or fiscal year change
Sep 13, 2023 Sep 8, 2023
UPLOAD Letter from the SEC Aug 14, 2023 —
CORRESP Letter to the SEC Aug 10, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
UPLOAD Letter from the SEC Jul 28, 2023 —
8-K Current report
Other events
Jul 5, 2023 Jul 5, 2023
8-K Current report
Shareholder vote results
May 8, 2023 May 4, 2023
8-K Current report
Material agreement, Agreement ended
May 1, 2023 Apr 26, 2023
424B5 Prospectus supplement May 1, 2023 —
S-3ASR Automatic shelf registration May 1, 2023 —
10-Q Quarterly report May 1, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 1, 2023 May 1, 2023
DEF 14A Proxy statement Mar 27, 2023 —
8-K Current report
Officer or director change
Mar 17, 2023 Mar 16, 2023
ARS Annual report to shareholders Mar 16, 2023 Dec 31, 2022
PRE 14A Preliminary proxy statement Mar 16, 2023 —
8-K Current report
Other events
Mar 10, 2023 Mar 10, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Other events
Jan 24, 2023 Jan 24, 2023
8-K Current report
Bylaw or fiscal year change
Dec 22, 2022 Dec 19, 2022
8-K Current report
Material agreement, Other events
Nov 22, 2022 Nov 18, 2022
424B5 Prospectus supplement Nov 21, 2022 —
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
8-K Current report
Regulation FD disclosure
Nov 3, 2022 Nov 3, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 27, 2022 Oct 13, 2022
8-K Current report
Regulation FD disclosure
Sep 23, 2022 Sep 22, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
424B5 Prospectus supplement Jul 29, 2022 —
S-8 Employee stock plan registration Jun 10, 2022 —
8-K Current report
Shareholder vote results
May 9, 2022 May 5, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
8-K Current report
Regulation FD disclosure
Apr 26, 2022 Apr 26, 2022
DEF 14A Proxy statement Mar 24, 2022 Dec 31, 2021
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
8-K Current report
Officer or director change
Jan 6, 2022 Jan 5, 2022
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Regulation FD disclosure, Other events
Aug 3, 2021 Jul 29, 2021
8-K Current report
Results of operations
Aug 3, 2021 Aug 3, 2021
8-K Current report
Material agreement, Other events
Jun 21, 2021 Jun 21, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 14, 2021 Jun 14, 2021
8-K Current report
Shareholder vote results
May 6, 2021 May 6, 2021
10-Q Quarterly report Apr 29, 2021 Mar 31, 2021
8-K Current report
Results of operations
Apr 21, 2021 Apr 21, 2021
DEF 14A Proxy statement Mar 31, 2021 Dec 31, 2020
10-K Annual report Mar 23, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 23, 2021 Mar 23, 2021
8-K Current report
Material agreement, Other events
Mar 11, 2021 Mar 11, 2021
8-K Current report
Material agreement, Other events
Feb 12, 2021 Feb 12, 2021
424B5 Prospectus supplement Feb 12, 2021 —
S-3ASR Automatic shelf registration Feb 10, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Feb 8, 2021 Feb 8, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 6, 2021 Jan 6, 2021
8-K Current report
Bylaw or fiscal year change
Dec 11, 2020 Dec 11, 2020
424B5 Prospectus supplement Nov 16, 2020 —
8-K Current report
Material agreement, Other events
Nov 13, 2020 Nov 13, 2020
FWP Free writing prospectus Nov 13, 2020 —
8-K Current report
Other events
Nov 13, 2020 Nov 13, 2020
424B5 Prospectus supplement Nov 12, 2020 —
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Regulation FD disclosure, Other events
Nov 4, 2020 Nov 4, 2020
8-K Current report
Regulation FD disclosure, Other events
Sep 14, 2020 Sep 14, 2020
8-K Current report
Material agreement, New debt
Sep 10, 2020 Sep 10, 2020
8-K Current report
Officer or director change
Sep 1, 2020 Sep 1, 2020
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 12, 2020 Aug 12, 2020
8-K Current report
Regulation FD disclosure
Jul 15, 2020 Jul 15, 2020
8-K Current report
Officer or director change
Jun 19, 2020 Jun 19, 2020
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2020 Jun 3, 2020
8-K Current report
Other events
May 15, 2020 May 15, 2020
8-K Current report
Shareholder vote results
May 11, 2020 May 11, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
EFFECT Filing May 5, 2020 —
424B2 Prospectus May 5, 2020 —
CORRESP Letter to the SEC May 1, 2020 —
CORRESP Letter to the SEC Apr 9, 2020 —
S-3/A Filing Apr 9, 2020 —
UPLOAD Letter from the SEC Apr 2, 2020 —
S-3 Shelf registration Mar 27, 2020 —
DEF 14A Proxy statement Mar 26, 2020 Mar 26, 2020
10-K Annual report Mar 26, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 26, 2020 Mar 26, 2020
8-K Current report
Regulation FD disclosure, Other events
Dec 6, 2019 Dec 6, 2019
10-Q Quarterly report Oct 29, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 29, 2019 Oct 29, 2019
8-K Current report
Other events
Sep 9, 2019 Sep 9, 2019
10-Q Quarterly report Aug 12, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 12, 2019 Aug 12, 2019
8-K Current report
Shareholder vote results
May 9, 2019 May 9, 2019
10-Q Quarterly report May 2, 2019 Mar 31, 2019
8-K Current report
Results of operations
Apr 29, 2019 Apr 29, 2019
DEF 14A Proxy statement Mar 29, 2019 Mar 29, 2019
10-K Annual report Mar 29, 2019 Dec 31, 2018
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Mar 27, 2019 Mar 27, 2019
8-K Current report
Results of operations
Mar 25, 2019 Mar 25, 2019
8-K Current report
Agreement ended
Mar 22, 2019 Mar 22, 2019
8-K Current report
Other events
Feb 8, 2019 Feb 8, 2019
EFFECT Filing Jan 30, 2019 —
CORRESP Letter to the SEC Jan 28, 2019 —
UPLOAD Letter from the SEC Dec 21, 2018 —
S-1 Registration statement Dec 18, 2018 —
10-Q Quarterly report Oct 30, 2018 Sep 30, 2018
8-K Current report
Results of operations
Oct 29, 2018 Oct 29, 2018
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 11, 2018 Oct 11, 2018
8-K Current report
Regulation FD disclosure
Oct 4, 2018 Oct 4, 2018
8-K Current report
Other events
Oct 3, 2018 Oct 2, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
FLNA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Austin, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1069530
Former names
CASSAVA SCIENCES INC (until Feb 19, 2026); PAIN THERAPEUTICS INC (until Mar 25, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.